BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McElvaney OJ, Curley GF, Rose-John S, McElvaney NG. Interleukin-6: obstacles to targeting a complex cytokine in critical illness. Lancet Respir Med 2021;9:643-54. [PMID: 33872590 DOI: 10.1016/S2213-2600(21)00103-X] [Cited by in Crossref: 50] [Cited by in F6Publishing: 57] [Article Influence: 50.0] [Reference Citation Analysis]
Number Citing Articles
1 Fathy A, Rizk A, Elnekeidy A, Gharraf HS, Abdelgawad MS, Samir A. Imaging of COVID-19 vasculopathy from head to toe: Egyptian collective experience after 2 years of the pandemic. Egypt J Radiol Nucl Med 2022;53:139. [DOI: 10.1186/s43055-022-00815-y] [Reference Citation Analysis]
2 Gong H, Chen Y, Chen M, Li J, Zhang H, Yan S, Lv C. Advanced development and mechanism of sepsis-related acute respiratory distress syndrome. Front Med 2022;9. [DOI: 10.3389/fmed.2022.1043859] [Reference Citation Analysis]
3 Nasonov EL, Feist E. The prospects of interleukin-6 inhibition in rheumatoid arthritis: Olokizumab (novel monoclonal antibodies to IL-6). Naučno-praktičeskaâ revmatologiâ 2022;60:505-518. [DOI: 10.47360/1995-4484-2022-505-518] [Reference Citation Analysis]
4 Kalpachidou T, Riehl L, Schöpf CL, Ucar B, Kress M. Proinflammatory cytokines and their receptors as druggable targets to alleviate pathological pain. PAIN 2022;163:S79-S98. [DOI: 10.1097/j.pain.0000000000002737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Cheng Q, Zhang X, Chen LS, Liu J. Mendelian randomization accounting for complex correlated horizontal pleiotropy while elucidating shared genetic etiology. Nat Commun 2022;13:6490. [DOI: 10.1038/s41467-022-34164-1] [Reference Citation Analysis]
6 Wang N, Li E, Deng H, Yue L, Zhou L, Su R, He B, Lai C, Li G, Gao Y, Zhou W, Gao Y. Inosine: a broad-spectrum anti-inflammatory against SARS-CoV-2 infection-induced acute lung injury via suppressing TBK1 phosphorylation. J Pharm Anal 2022. [PMID: 36313960 DOI: 10.1016/j.jpha.2022.10.002] [Reference Citation Analysis]
7 Huang B, Luo J, Liu LY, Deng WS, Wang K, Lu HS, Kong JL. Deciphering the Mechanism of YuPingFeng Granules in Treating Pneumonia: A Network Pharmacology and Molecular Docking Study. Evid Based Complement Alternat Med 2022;2022:4161235. [PMID: 36285159 DOI: 10.1155/2022/4161235] [Reference Citation Analysis]
8 Tian C, Wang Z, Huang L, Liu Y, Wu K, Li Z, Han B, Jiao D, Han X, Zhao Y. One-step fabrication of lidocaine/CalliSpheres® composites for painless transcatheter arterial embolization. J Transl Med 2022;20:463. [PMID: 36221084 DOI: 10.1186/s12967-022-03653-8] [Reference Citation Analysis]
9 Velankar KY, Mou M, Hartmeier PR, Clegg B, Gawalt ES, Jiang M, Meng WS. Recrystallization of Adenosine for Localized Drug Delivery. Mol Pharm 2022. [PMID: 36001090 DOI: 10.1021/acs.molpharmaceut.2c00527] [Reference Citation Analysis]
10 Wijaya IPEK, Pitoyo CW, Aditianingsih D, Shatri H, Nainggolan L. Local and Systemic Levels of IL-6 and IL-17 in Mechanically Ventilated Severe Pneumonia Patients.. [DOI: 10.21203/rs.3.rs-1931441/v1] [Reference Citation Analysis]
11 Gao X, Lin X, Ho C, Zhang Y, Li B, Chen Z. Chemical composition and anti-inflammatory activity of water extract from black cocoa tea (Camellia ptilophylla). Food Research International 2022. [DOI: 10.1016/j.foodres.2022.111831] [Reference Citation Analysis]
12 Rajendran M. Clinical course of critically ill non-COVID 19 ARDS patients using Itolizumab versus conventional treatment: A case series. IJIRM 2022;7:93-98. [DOI: 10.18231/j.ijirm.2022.022] [Reference Citation Analysis]
13 Zhang L, Li M, Wang W, Yu W, Liu H, Wang K, Chang M, Deng C, Ji Y, Shen Y, Qi L, Sun H. Celecoxib alleviates denervation-induced muscle atrophy by suppressing inflammation and oxidative stress and improving microcirculation. Biochem Pharmacol 2022;:115186. [PMID: 35882305 DOI: 10.1016/j.bcp.2022.115186] [Reference Citation Analysis]
14 Zhang J, Luo W, Miao C, Zhong J. Hypercatabolism and Anti-catabolic Therapies in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome. Front Nutr 2022;9:941097. [DOI: 10.3389/fnut.2022.941097] [Reference Citation Analysis]
15 Attallah OK, Mohammed TT, Al-anbari NN. Effect of Adding Grape Pomace and Resveratrol on Some Physiological Traits and Gene Expression to Prevent Hemorrhagic Fatty Liver Syndrome in Laying Hens. IOP Conf Ser : Earth Environ Sci 2022;1060:012076. [DOI: 10.1088/1755-1315/1060/1/012076] [Reference Citation Analysis]
16 Umehara T, Winstanley YE, Andreas E, Morimoto A, Williams EJ, Smith KM, Carroll J, Febbraio MA, Shimada M, Russell DL, Robker RL. Female reproductive life span is extended by targeted removal of fibrotic collagen from the mouse ovary. Sci Adv 2022;8:eabn4564. [PMID: 35714185 DOI: 10.1126/sciadv.abn4564] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Huang P, Zuo Q, Li Y, Oduro PK, Tan F, Wang Y, Liu X, Li J, Wang Q, Guo F, Li Y, Yang L. A Vicious Cycle: In Severe and Critically Ill COVID-19 Patients. Front Immunol 2022;13:930673. [DOI: 10.3389/fimmu.2022.930673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Wong CKH, Lau KTK, Au ICH, Xiong X, Chung MSH, Leung BYC, Lau EHY, Cowling BJ. Initiation of Tocilizumab or Baricitinib Were Associated With Comparable Clinical Outcomes Among Patients Hospitalized With COVID-19 and Treated With Dexamethasone. Front Pharmacol 2022;13:866441. [DOI: 10.3389/fphar.2022.866441] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Rodríguez-hernández MÁ, Carneros D, Núñez-núñez M, Coca R, Baena R, López-ruiz GM, Cano-serrano ME, Martínez-tellería A, Fuentes-lópez A, Praena-fernandez JM, Garbers C, Hernández-quero J, García F, Rose-john S, Bustos M. Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19. Front Immunol 2022;13:891456. [DOI: 10.3389/fimmu.2022.891456] [Reference Citation Analysis]
20 Jiménez D, Torres Arias M. Immunouniverse of SARS-CoV-2. Immunol Med 2022;:1-39. [PMID: 35502127 DOI: 10.1080/25785826.2022.2066251] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Xu Z, Liu A, Yang L, Zhang B, Zheng F, Zhang J, Zhan J. Changes in immune function and immunomodulatory treatments of septic patients. Clinical Immunology 2022. [DOI: 10.1016/j.clim.2022.109040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Li Q, Liu W, Feng Y, Hou H, Zhang Z, Yu Q, Zhou Y, Luo Q, Luo Y, Ouyang H, Zhang H, Zhu W. Radix Puerariae thomsonii polysaccharide (RPP) improves inflammation and lipid peroxidation in alcohol and high-fat diet mice by regulating gut microbiota. Int J Biol Macromol 2022;209:858-70. [PMID: 35439478 DOI: 10.1016/j.ijbiomac.2022.04.067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Hong W, Zhou X, Jin S, Lu Y, Pan J, Lin Q, Yang S, Xu T, Basharat Z, Zippi M, Fiorino S, Tsukanov V, Stock S, Grottesi A, Chen Q, Pan J. A Comparison of XGBoost, Random Forest, and Nomograph for the Prediction of Disease Severity in Patients With COVID-19 Pneumonia: Implications of Cytokine and Immune Cell Profile. Front Cell Infect Microbiol 2022;12:819267. [DOI: 10.3389/fcimb.2022.819267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zhang L, Zhang J, He H, Ling X, Li F, Yang Z, Zhao J, Li H, Yang T, Zhao S, Shi K, Guan X, Zhao R, Li Z. Increased Cytokine Levels Assist in the Diagnosis of Respiratory Bacterial Infections or Concurrent Bacteremia in Patients With Non-Hodgkin’s Lymphoma. Front Cell Infect Microbiol 2022;12:860526. [DOI: 10.3389/fcimb.2022.860526] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Zhao C, Xie R, Qian Q, Yan J, Wang H, Wang X. Triclosan induced zebrafish immunotoxicity by targeting miR-19a and its gene socs3b to activate IL-6/STAT3 signaling pathway. Sci Total Environ 2022;815:152916. [PMID: 34998771 DOI: 10.1016/j.scitotenv.2022.152916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Li J, Chen Y, Liu Q, Tian Z, Zhang Y. Mechanistic and therapeutic links between rheumatoid arthritis and diabetes mellitus. Clin Exp Med. [DOI: 10.1007/s10238-022-00816-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Rajasundaram S, Burgess S, Gill D. Treatment of severe covid-19 with interleukin 6 receptor inhibition. bmjmed 2022;1:e000144. [DOI: 10.1136/bmjmed-2022-000144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Visser MPJ, Dofferhoff ASM, van den Ouweland JMW, van Daal H, Kramers C, Schurgers LJ, Janssen R, Walk J. Effects of Vitamin D and K on Interleukin-6 in COVID-19. Front Nutr 2022;8:761191. [DOI: 10.3389/fnut.2021.761191] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
29 Masterson CH, Ceccato A, Artigas A, Dos Santos C, Rocco PR, Rolandsson Enes S, Weiss DJ, McAuley D, Matthay MA, English K, Curley GF, Laffey JG. Mesenchymal stem/stromal cell-based therapies for severe viral pneumonia: therapeutic potential and challenges. Intensive Care Med Exp 2021;9:61. [PMID: 34970706 DOI: 10.1186/s40635-021-00424-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Li Z, Yang Z, Hu P, Guan X, Zhang L, Zhang J, Yang T, Zhang C, Zhao R. Cytokine Expression of Lung Bacterial Infection in Newly Diagnosed Adult Hematological Malignancies. Front Immunol 2021;12:748585. [PMID: 34925324 DOI: 10.3389/fimmu.2021.748585] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Leung E, Crass RL, Jorgensen SCJ, Raybardhan S, Langford BJ, Moore WJ, Rhodes NJ. Pharmacokinetic/Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19. Clin Pharmacokinet 2021. [PMID: 34894345 DOI: 10.1007/s40262-021-01092-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
32 Kiselevskii MV, Vlasenko RY, Stepanyan NG, Shubina IZ, Sitdikova SM, Kirgizov KI, Varfolomeeva SR. Secretome of Mesenchymal Bone Marrow Stem Cells: Is It Immunosuppressive or Proinflammatory? Bull Exp Biol Med 2021;172:250-3. [PMID: 34855084 DOI: 10.1007/s10517-021-05371-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
33 Pan D, Kim JW, Nazareth J, Assadi S, Bellass A, Leach J, Brosnan JG, Ahmed A, Starcevic F, Sze S, Martin CA, Williams CM, Barer MR, Sahota A, Patel P, Tattersall A, Cooper A, Pareek M, Haldar P. Quantification and prognostic significance of interferon-γ secreting SARS-CoV-2 responsive T cells in hospitalized patients with acute COVID-19. J Infect 2021:S0163-4453(21)00554-5. [PMID: 34801527 DOI: 10.1016/j.jinf.2021.11.010] [Reference Citation Analysis]
34 Korotaeva AA, Samoilova EV, Mindzaev DR, Nasonova SN, Zhirov IV, Tereschenko SN. Pro-inflammatory cytokines in chronic cardiac failure: state of problem. Terapevticheskii arkhiv 2021;93:1389-94. [DOI: 10.26442/00403660.2021.11.201170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Rahn S, Becker-Pauly C. Meprin and ADAM proteases as triggers of systemic inflammation in sepsis. FEBS Lett 2021. [PMID: 34762736 DOI: 10.1002/1873-3468.14225] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Zhou S, Zhong Z, Huang P, Xiang B, Li X, Dong H, Zhang G, Wu Y, Li P. IL-6/STAT3 Induced Neuron Apoptosis in Hypoxia by Downregulating ATF6 Expression. Front Physiol 2021;12:729925. [PMID: 34744770 DOI: 10.3389/fphys.2021.729925] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
37 Maraolo AE, Crispo A, Piezzo M, Di Gennaro P, Vitale MG, Mallardo D, Ametrano L, Celentano E, Cuomo A, Ascierto PA, Cascella M. The Use of Tocilizumab in Patients with COVID-19: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Studies. J Clin Med 2021;10:4935. [PMID: 34768455 DOI: 10.3390/jcm10214935] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
38 Dąbrowska E, Galińska-Skok B, Waszkiewicz N. Depressive and Neurocognitive Disorders in the Context of the Inflammatory Background of COVID-19. Life (Basel) 2021;11:1056. [PMID: 34685427 DOI: 10.3390/life11101056] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
39 Nishimura Y, Fajgenbaum DC, Pierson SK, Iwaki N, Nishikori A, Kawano M, Nakamura N, Izutsu K, Takeuchi K, Nishimura MF, Maeda Y, Otsuka F, Yoshizaki K, Oksenhendler E, van Rhee F, Sato Y. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease. Am J Hematol 2021;96:1241-52. [PMID: 34265103 DOI: 10.1002/ajh.26292] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 20.0] [Reference Citation Analysis]
40 Martins LVDO, Sacilotto NDC. Interleucina-6. Rev Paul Reumatol 2021. [DOI: 10.46833/reumatologiasp.2021.20.3.12-21] [Reference Citation Analysis]
41 Pan D, Kim JW, Nazareth J, Assadi S, Bellass A, Leach J, Brosnan JG, Ahmed A, Starcevic F, Sze S, Martin CA, Williams CM, Barer MR, Sahota A, Patel P, Tattersall A, Cooper A, Pareek M, Haldar P. Quantification and prognostic significance of interferon-γ secreting SARS-CoV-2 responsive T cells in hospitalised patients with acute COVID-19.. [DOI: 10.1101/2021.09.21.21263902] [Reference Citation Analysis]
42 Mert A, Vahaboğlu H, Arslan F, Batirel A, Saraçoğlu KT, Bastug A, Çağatay A, Irmak İ, Dizman GT, Ertenli İ, Altunal LN, Sengel BE, Bayram M, Omma A, Amikishiyev S, Aypak A, Bes C, Bolukçu S, Içten S, Topeli A, Bektaş M, Arslan BY, Öztürk S, Çomoğlu Ş, Aydin S, Küçükşahin O, Içaçan OC, Ince B, Aghamuradov S, Mutlu MY, Şimşek F, Emre S, Ustun C, Ergen P, Aydin Ö, Koç MM, Sevindik ÖG, Odabaşı Z, Korten V, Bodur H, Güner R, Ünal S, Kocak M, Gül A. Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls. Rheumatol Int 2021. [PMID: 34515808 DOI: 10.1007/s00296-021-04965-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Leung E, Jorgensen SC, Crass RL, Raybardhan S, Langford B, Moore WJ, Rhodes NJ. Pharmacokinetic /Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19.. [DOI: 10.1101/2021.08.28.21262692] [Reference Citation Analysis]
44 Arulkumaran N, Snow TAC, Kulkarni A, Brealey D, Rickman H, Rees-Spear C, Spyer MJ, Heaney J, Garr E, Williams B, Cherepanov P, Kassiotis G, Lunn M, Houlihan C, McCoy LE, Nastouli E, Singer M. Defining Potential Therapeutic Targets in Coronavirus Disease 2019: A Cross-Sectional Analysis of a Single-Center Cohort. Crit Care Explor 2021;3:e0488. [PMID: 34386774 DOI: 10.1097/CCE.0000000000000488] [Reference Citation Analysis]
45 Wong KK, Lee SWH, Kua KP. N-Acetylcysteine as Adjuvant Therapy for COVID-19 - A Perspective on the Current State of the Evidence. J Inflamm Res 2021;14:2993-3013. [PMID: 34262324 DOI: 10.2147/JIR.S306849] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
46 Lee CCE, Ali K, Connell D, Mordi IR, George J, Lang EM, Lang CC. COVID-19-Associated Cardiovascular Complications. Diseases 2021;9:47. [PMID: 34209705 DOI: 10.3390/diseases9030047] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 19.0] [Reference Citation Analysis]
47 Tamayo-Velasco Á, Martínez-Paz P, Peñarrubia-Ponce MJ, de la Fuente I, Pérez-González S, Fernández I, Dueñas C, Gómez-Sánchez E, Lorenzo-López M, Gómez-Pesquera E, Heredia-Rodríguez M, Carnicero-Frutos I, Muñoz-Moreno MF, Bernardo D, Álvarez FJ, Tamayo E, Gonzalo-Benito H. HGF, IL-1α, and IL-27 Are Robust Biomarkers in Early Severity Stratification of COVID-19 Patients. J Clin Med 2021;10:2017. [PMID: 34066892 DOI: 10.3390/jcm10092017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]